Life Science Investing Anavex Life Sciences Announces Presentation at the 35th Alzheimer Europe Conference 'Connecting Science and Communities: The Future of Dementia Care'
Life Science Investing Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics 2025
Life Science Investing Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
Life Science Investing Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection
Life Science Investing Stoke Therapeutics and Biogen Present New Data at the 54th Child Neurology Society Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
Life Science Investing Biogen and Stoke Therapeutics Present New Data at the 54th Child Neurology Society Annual Meeting that Support the Potential of Zorevunersen as a Disease-Modifying Medicine for Dravet Syndrome
Life Science Investing Royalty Pharma to Announce Third Quarter 2025 Financial Results on November 5, 2025
Life Science Investing Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
Life Science Investing Gilead Sciences to Release Third Quarter 2025 Financial Results on Thursday, October 30, 2025
Life Science Investing Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
Life Science Investing RenovoRx Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD
Life Science Investing Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting
Life Science Investing Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention
